ARCHIVES

Trial Data: No Benefit In Adding Perifosine to Capecitabine

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Administration Ignores Congressional Mandate To Revive Training Grants, Funds Fellowships

February 8, 1974

ASCO/AUA Suggest 5-ARIs To Cut Prostate Cancer Risk

February 27, 2009

DCBD Board Okays Concept For New Cytogenetics RFA

August 3, 1984

Scientists, Industry Identify Barriers To Development of Molecular Therapies

April 12, 2002

Senate Passes Budget; Broder; Fiscal 93 Great Year – Not

September 25, 1992

National Cancer Policy Board a Successful Experiment, NCI Says; Funding Extended

May 19, 2000